Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial

Manon Gouez, Olivia Pérol, Maurice Pérol, Christophe Caux, Christine Ménétrier-Caux, Marine Villard, Thierry Walzer, Lidia Delrieu, Pierre Saintigny, Philippe Marijnen, Vincent Pialoux, Béatrice Fervers, Manon Gouez, Olivia Pérol, Maurice Pérol, Christophe Caux, Christine Ménétrier-Caux, Marine Villard, Thierry Walzer, Lidia Delrieu, Pierre Saintigny, Philippe Marijnen, Vincent Pialoux, Béatrice Fervers

Abstract

Introduction: Patients with metastatic non-small cell lung cancer (mNSCLC) suffer from numerous symptoms linked to disease and treatment which may further impair the patient's overall condition. In addition to its benefits on quality of life and fatigue, physical exercise may improve treatment response, notably due to its known effects on the immune system. The ERICA study is designed to assess the feasibility of a supervised acute physical exercise therapy realised immediately prior immune-chemotherapy infusion in patients with mNSCLC. Secondary objectives will examine the effects of acute exercise combined with an unsupervised home-walking programme on clinical, physical, psychosocial and biological parameters.

Methods and analysis: ERICA is a prospective, monocentric, randomised controlled, open-label feasibility study conducted at the Centre Léon Bérard Comprehensive Cancer Center (France). Thirty patients newly diagnosed with mNSCLC will be randomised (2:1 ratio) to the 'exercise' or the 'control' group. At baseline and during the last treatment cycle, participants in both groups will receive Physical Activity recommendations, and two nutritional assessments. In the exercise group, participants will receive a 3-month programme consisting of a supervised acute physical exercise session prior to immune-chemotherapy infusion, and an unsupervised home-based walking programme with an activity tracker. The acute exercise consists of 35 min interval training at submaximal intensity scheduled to terminate 15 min prior to infusion. Clinical, physical, biological and psychosocial parameters will be assessed at baseline, 3 and 6 months after inclusion. Biological measures will include immune, inflammatory, metabolic, oxidative stress biomarkers and molecular profiling.

Ethics and dissemination: The study protocol was approved by the French ethics committee (Comité de protection des personnes Ile de France II, N°ID-RCB 20.09.04.65226, 8 December 2020). The study is registered on ClinicalTrials.gov (NCT number:NCT04676009) and is at the pre-results stage. All participants will sign an informed consent form. The findings will be disseminated in peer-reviewed journals and academic conferences.

Keywords: Adult oncology; CHEMOTHERAPY; IMMUNOLOGY; Respiratory tract tumours; SPORTS MEDICINE.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flowchart of the ERICA study, France (original flowchart).

References

    1. Planchard D, Popat S, Kerr K, et al. . Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2018;29:iv192–237. 10.1093/annonc/mdy275
    1. ASCO . Lung Cancer - Non-Small Cell - Statistics [Internet]. [cited 2021 Jul 3] 2021.
    1. Gadgeel S, Rodríguez-Abreu D, Speranza G, et al. . Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic Nonsquamous non-small-cell lung cancer. J Clin Oncol 2020;38:1505–17. JCO.19. 10.1200/JCO.19.03136
    1. Low JL, Walsh RJ, Ang Y, et al. . The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer. Ther Adv Med Oncol 2019;11:1758835919870360 10.1177/1758835919870360
    1. Brahmer JR, Rodríguez-Abreu D, Robinson AG, et al. . Health-Related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. Lancet Oncol 2017;18:1600–9. 10.1016/S1470-2045(17)30690-3
    1. Polanski J, Jankowska-Polanska B, Rosinczuk J, et al. . Quality of life of patients with lung cancer. Onco Targets Ther 2016;9:1023–8. 10.2147/OTT.S100685
    1. Camps C, del Pozo N, Blasco A, et al. . Importance of quality of life in patients with non-small-cell lung cancer. Clin Lung Cancer 2009;10:83–90. 10.3816/CLC.2009.n.010
    1. Garassino MC, Gadgeel S, Esteban E, et al. . Patient-Reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol 2020;21:387–97. 10.1016/S1470-2045(19)30801-0
    1. Steffen McLouth LE, Lycan TW, Levine BJ, et al. . Patient-Reported outcomes from patients receiving immunotherapy or chemoimmunotherapy for metastatic non-small-cell lung cancer in clinical practice. Clin Lung Cancer 2020;21:255–63. 10.1016/j.cllc.2019.11.015
    1. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985;100:126–31.
    1. Hwang C-L, Yu C-J, Shih J-Y, et al. . Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy. Support Care Cancer 2012;20:3169–77. 10.1007/s00520-012-1452-5
    1. Chen H-M, Tsai C-M, Wu Y-C, et al. . Effect of walking on circadian rhythms and sleep quality of patients with lung cancer: a randomised controlled trial. Br J Cancer 2016;115:1304–12. 10.1038/bjc.2016.356
    1. Dhillon HM, Bell ML, van der Ploeg HP, et al. . Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol 2017;28:1889–97. 10.1093/annonc/mdx205
    1. Zhang L-L, Wang S-Z, Chen H-L, et al. . Tai chi exercise for cancer-related fatigue in patients with lung cancer undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage 2016;51:504–11. 10.1016/j.jpainsymman.2015.11.020
    1. Peddle-McIntyre CJ, Singh F, Thomas R, et al. . Exercise training for advanced lung cancer. Cochrane Database Syst Rev 2019;28 10.1002/14651858.CD012685.pub2
    1. Quist M, Adamsen L, Rørth M, et al. . The impact of a multidimensional exercise intervention on physical and functional capacity, anxiety, and depression in patients with advanced-stage lung cancer undergoing chemotherapy. Integr Cancer Ther 2015;14:341–9. 10.1177/1534735415572887
    1. Avancini A, Sartori G, Gkountakos A. Physical activity and exercise in lung cancer care: will promises be fulfilled? Oncologist 2020;25:e555–69 10.1634/theoncologist.2019-0463
    1. Activité physique . Prévention et traitement des maladies chroniques Éditions EDP Sciences, janvier 2019, 824 pages, Collection Expertise collective ISBN 978-2-7598-2328-4 [Internet]. Available:
    1. Koelwyn GJ, Quail DF, Zhang X, et al. . Exercise-dependent regulation of the tumour microenvironment. Nat Rev Cancer 2017;17:620–32. 10.1038/nrc.2017.78
    1. Nieman DC, Wentz LM. The compelling link between physical activity and the body's defense system. J Sport Health Sci 2019;8:201–17. 10.1016/j.jshs.2018.09.009
    1. Bigley AB, Rezvani K, Chew C, et al. . Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Brain Behav Immun 2014;39:160–71. 10.1016/j.bbi.2013.10.030
    1. Idorn M, Hojman P. Exercise-Dependent regulation of NK cells in cancer protection. Trends Mol Med 2016;22:565–77. 10.1016/j.molmed.2016.05.007
    1. Pedersen L, Idorn M, Olofsson GH, et al. . Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab 2016;23:554–62. 10.1016/j.cmet.2016.01.011
    1. Wadley AJ, Cullen T, Vautrinot J, et al. . High intensity interval exercise increases the frequency of peripheral PD-1+ CD8+ central memory T-cells and soluble PD-L1 in humans. Brain Behav Immun Health 2020;3:100049. 10.1016/j.bbih.2020.100049
    1. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000;80:1055–81. 10.1152/physrev.2000.80.3.1055
    1. Wiggins JM, Opoku-Acheampong AB, Baumfalk DR, et al. . Exercise and the tumor microenvironment: potential therapeutic implications. Exerc Sport Sci Rev 2018;46:56–64. 10.1249/JES.0000000000000137
    1. McCullough DJ, Stabley JN, Siemann DW, et al. . Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J Natl Cancer Inst 2014;106:dju036 10.1093/jnci/dju036
    1. Schadler KL, Thomas NJ, Galie PA, et al. . Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy. Oncotarget 2016;7:65429–40. 10.18632/oncotarget.11748
    1. Schumacher O, Galvão DA, Taaffe DR, et al. . Exercise modulation of tumour perfusion and hypoxia to improve radiotherapy response in prostate cancer. Prostate Cancer Prostatic Dis 2021;24:1–14. 10.1038/s41391-020-0245-z
    1. Thomas VJ, Seet-Lee C, Marthick M, et al. . Aerobic exercise during chemotherapy infusion for cancer treatment: a novel randomised crossover safety and feasibility trial. Support Care Cancer 2020;28:625–32. 10.1007/s00520-019-04871-5
    1. Kerrigan K. A pilot study of aerobic exercise performed in breast cancer patients during chemotherapy infusion. | Journal of Clinical Oncology [Internet], 2010. Available:
    1. Ashcraft KA, Warner AB, Jones LW, et al. . Exercise as adjunct therapy in cancer. Semin Radiat Oncol 2019;29:16–24. 10.1016/j.semradonc.2018.10.001
    1. Martín-Ruiz A, Fiuza-Luces C, Rincón-Castanedo C, et al. . Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma. Exerc Immunol Rev 2020;26:100–15.
    1. Haute Autorité de santé . Diagnostic de la dénutrition de l’enfant et de l’adulte : Méthode Recommandations pour la pratique clinique., 2019. Available: [Accessed 29th March 2022].
    1. Macmillan Cancer Support . Physical activity in patients with metastatic bone disease: Guidance for healthcare professionals [Internet], 2018. Available: [Accessed cited 2021 Jul 4].
    1. Senesse P, Bachmann P, Bensadoun RJ, et al. . Nutrition chez le patient adulte atteint de cancer : textes courts. Nutrition Clinique et Métabolisme 2012;26:151–8. 10.1016/j.nupar.2012.10.002
    1. Arends J, Bachmann P, Baracos V, et al. . ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017;36:11–48. 10.1016/j.clnu.2016.07.015
    1. Tudor-Locke C, Craig CL, Aoyagi Y, et al. . How many steps/day are enough? for older adults and special populations. Int J Behav Nutr Phys Act 2011;8:80. 10.1186/1479-5868-8-80
    1. Borg G, Hassmén P, Lagerström M. Perceived exertion related to heart rate and blood lactate during arm and leg exercise. Eur J Appl Physiol Occup Physiol 1987;56:679–85. 10.1007/BF00424810
    1. Kilgour RD, Vigano A, Trutschnigg B, et al. . Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 2013;21:3261–70. 10.1007/s00520-013-1894-4
    1. Anand A, Gajra A. Hand Grip Dynamometry as Prognostic and Predictive Marker in Older Patients With Cancer. J Gerontol Geriatr Res [Internet], 2018. Available:
    1. Trutschnigg B, Kilgour RD, Reinglas J, et al. . Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab 2008;33:1232–9. 10.1139/H08-122
    1. Amireault S, Godin G, Lacombe J, et al. . The use of the Godin-Shephard leisure-time physical activity questionnaire in oncology research: a systematic review. BMC Med Res Methodol 2015;15:60 10.1186/s12874-015-0045-7
    1. Binay Safer V, Safer U. Usefulness and limitations of single-slice computed tomography analysis at the third lumbar region in the assessment of sarcopenia. Crit Care 2013;17:466. 10.1186/cc13123
    1. Boutin RD, Yao L, Canter RJ, et al. . Sarcopenia: current concepts and imaging implications. AJR Am J Roentgenol 2015;205:W255–66. 10.2214/AJR.15.14635
    1. Heymsfield SB, Smith R, Aulet M, et al. . Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 1990;52:214–8. 10.1093/ajcn/52.2.214
    1. Miller KD, Jones E, Yanovski JA, et al. . Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871–5. 10.1016/S0140-6736(97)11518-5
    1. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. . Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998;85:115–22. 10.1152/jappl.1998.85.1.115
    1. Mourtzakis M, Prado CMM, Lieffers JR, et al. . A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008;33:997–1006. 10.1139/H08-075
    1. Thibault R, Goujon N, Le Gallic E, et al. . Use of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk. Clin Nutr 2009;28:134–40. 10.1016/j.clnu.2009.01.003
    1. Hjermstad MJ, Fossa SD, Bjordal K, et al. . Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. J Clin Oncol 1995;13:1249–54. 10.1200/JCO.1995.13.5.1249
    1. Koller M, Shamieh O, Hjermstad MJ, et al. . Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol 2020;21:723–32. 10.1016/S1470-2045(20)30093-0
    1. Bergman B, Aaronson NK, Ahmedzai S, et al. . The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 1994;30:635–42. 10.1016/0959-8049(94)90535-5
    1. Weis J, Tomaszewski KA, Hammerlid E, et al. . International psychometric validation of an EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12). JNCI: Journal of the National Cancer Institute 2017;109 10.1093/jnci/djw273
    1. Savard M-H, Savard J, Simard S. Empirical validation of the insomnia severity index in cancer patients: insomnia severity index and cancer. Psycho-Oncology 2005;14:429–41.
    1. Morin CM, Belleville G, Bélanger L, et al. . The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011;34:601–8. 10.1093/sleep/34.5.601
    1. Sass C, Dupré C, Giordanella JP. Le score Epices : un score individuel de précarité. Construction du score et mesure des relations avec des données de santé, dans une population de 197 389 personnes. Bulletin Epidemiologique Hebdomadaire 2006;4:93–6
    1. Jones LW. Precision oncology framework for investigation of exercise as treatment for cancer. J Clin Oncol 2015;33:4134–7. 10.1200/JCO.2015.62.7687
    1. Billingham SAM, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom clinical research network database. BMC Med Res Methodol 2013;13:104. 10.1186/1471-2288-13-104
    1. R Core Team . European Environment Agency [Internet], 2020. Available:
    1. Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 10.1016/j.jbi.2008.08.010
    1. Harris PA, Taylor R, Minor BL, et al. . The REDCap Consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208. 10.1016/j.jbi.2019.103208
    1. Jones LW. Physical activity and lung cancer survivorship. In: Courneya KS, Friedenreich CM, editors. Physical Activity and Cancer [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg 2010.
    1. Quist M, Langer SW, Lillelund C, et al. . Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial. Lung Cancer 2020;145:76–82. 10.1016/j.lungcan.2020.05.003
    1. Nadler M, Bainbridge D, Tomasone J, et al. . Oncology care provider perspectives on exercise promotion in people with cancer: an examination of knowledge, practices, barriers, and facilitators. Support Care Cancer 2017;25:2297–304. 10.1007/s00520-017-3640-9
    1. Wilk M, Kepski J, Kepska J, et al. . Exercise interventions in metastatic cancer disease: a literature review and a brief discussion on current and future perspectives. BMJ Support Palliat Care 2020;10:404–10. 10.1136/bmjspcare-2020-002487
    1. Singh B, Spence R, Steele ML, et al. . Exercise for individuals with lung cancer: a systematic review and meta-analysis of adverse events, feasibility, and effectiveness. Semin Oncol Nurs 2020;36:151076. 10.1016/j.soncn.2020.151076
    1. Granger CL, Parry SM, Edbrooke L, et al. . Improving the delivery of physical activity services in lung cancer: a qualitative representation of the patient's perspective. Eur J Cancer Care 2019;28:e12946. 10.1111/ecc.12946
    1. Dittus KL, Gramling RE, Ades PA. Exercise interventions for individuals with advanced cancer: a systematic review. Prev Med 2017;104:124–32. 10.1016/j.ypmed.2017.07.015
    1. Heywood R, McCarthy AL, Skinner TL. Safety and feasibility of exercise interventions in patients with advanced cancer: a systematic review. Support Care Cancer 2017;25:3031–50. 10.1007/s00520-017-3827-0
    1. Yang M, Liu L, Gan C-E, et al. . Effects of home-based exercise on exercise capacity, symptoms, and quality of life in patients with lung cancer: a meta-analysis. Eur J Oncol Nurs 2020;49:101836. 10.1016/j.ejon.2020.101836
    1. Nieman DC, Lila MA, Gillitt ND. Immunometabolism: a multi-omics approach to interpreting the influence of exercise and diet on the immune system. Annu Rev Food Sci Technol 2019;10:341–63. 10.1146/annurev-food-032818-121316
    1. Gresham G, Schrack J, Gresham LM, et al. . Wearable activity monitors in oncology trials: current use of an emerging technology. Contemp Clin Trials 2018;64:13–21. 10.1016/j.cct.2017.11.002
    1. Haberlin C, O'Dwyer T, Mockler D, et al. . The use of eHealth to promote physical activity in cancer survivors: a systematic review. Support Care Cancer 2018;26:3323–36. 10.1007/s00520-018-4305-z
    1. Turner RR, Steed L, Quirk H, et al. . Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst Rev 2018;9:CD010192 10.1002/14651858.CD010192.pub3
    1. Naito T, Mitsunaga S, Miura S, et al. . Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle 2019;10:73–83. 10.1002/jcsm.12351
    1. Delrieu L, Anota A, Trédan O, et al. . Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial. BMC Cancer 2020;20:622 10.1186/s12885-020-07093-9
    1. Delrieu L, Martin A, Touillaud M. Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the able feasibility trial. Breast Cancer Res Treat 2021;188:601–13. [cited 2021 Jun 13]; Available from 10.1007/s10549-021-06238-z

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit